Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
01/1996
01/04/1996CA2193954A1 Targeted gene delivery system
01/04/1996CA2193827A1 Inducible nitric oxide synthase gene for treatment of disease
01/04/1996CA2193812A1 Improvements in or relating to delivery of nucleic acids
01/04/1996CA2193373A1 Ribozymes with optimized hybridizing arms, stems, and loops, trna embedded ribozymes and compositions thereof
01/03/1996EP0690129A1 Novel entities for cancer therapy
01/03/1996EP0689604A1 Process for preparing cancer vaccines
01/03/1996EP0689602A1 Delivery system controlled through factors associated with hiv and cell
01/03/1996EP0689601A1 Production of high titer helper-free retroviruses by transient transfection
01/03/1996EP0689596A1 Stimulation of immune response by viral protein
01/03/1996EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector
01/03/1996EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use
01/03/1996EP0689447A1 Cytopathic viruses for therapy and prophylaxis of neoplasia
01/03/1996EP0689421A1 Reduced and controlled surface binding of biologically active molecules
01/03/1996EP0626012A4 Homogenotization of gene-targeting events.
12/1995
12/28/1995WO1995035372A1 5-lipoxygenase-activating protein ii
12/28/1995WO1995035032A1 SUPPRESSION OF NUCLEAR FACTOR-kB DEPENDENT PROCESSES USING OLIGONUCLEOTIDES
12/28/1995WO1995024929A3 Polymeric gene delivery system
12/28/1995WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation
12/27/1995EP0688784A2 3'-Modified oligonucleotide derivatives
12/27/1995EP0688358A1 Improved vectors for gene therapy
12/27/1995EP0419621B1 Process for the specific replacement of a copy of a gene present in the receiver genome via the integration of a gene
12/27/1995EP0402402B1 Inhibition of htlv-iii by exogenous oligonucleotides
12/26/1995US5478745 Recombinant viral vector system
12/21/1995WO1995034671A1 Complementary adenoviral vector systems and cell lines
12/21/1995WO1995034670A2 Recombinant aav genome encoding immunodeficiency virus protein
12/21/1995WO1995034669A2 Retroviral gene therapy vectors and therapeutic methods based thereon
12/21/1995WO1995034661A1 Fas associated proteins
12/21/1995WO1995034659A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
12/21/1995WO1995034639A1 Novel retroviral envelope and ltr and retroviral vector particles including such envelope and/or ltr
12/21/1995WO1995034202A1 Methods for reducing hyperacute rejection of xenografts
12/21/1995WO1995032731A3 Immunogenic pharmaceuticals
12/21/1995WO1995030761A3 Methods of in vivo gene delivery
12/21/1995WO1995027512A3 Compositions and methods for gene therapy to treat disease
12/21/1995WO1995020660A3 Immunization by inoculation of dna transcription unit
12/21/1995CA2576396A1 Adeno-associated virus materials and methods
12/21/1995CA2192844A1 Fas associated proteins
12/21/1995CA2192660A1 Methods for reducing hyperacute rejection of xenografts
12/21/1995CA2191845A1 Retroviral gene therapy vectors and therapeutic methods based thereon
12/20/1995EP0687301A1 Prohormone convertase transformed cells and polypeptide synthesis
12/20/1995EP0687184A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
12/20/1995EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
12/20/1995EP0541722B1 Compounds and methods for inhibiting gene expression
12/19/1995US5476930 Thiophosphorylacetylamino linkage; reacting a thiophosphate compound with a bromoacetylamino compound
12/19/1995US5476782 DNA encoding a human 5-HT1E receptor and uses thereof
12/19/1995CA2069869C Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/14/1995WO1995033842A1 Safe retroviral vectors, their production and use
12/14/1995WO1995033841A1 Locus control subregions for integration-site independent transgene expression
12/14/1995WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy
12/14/1995WO1995033826A1 Transgenic mice expressing progressive cervico-vaginal neoplasia
12/14/1995WO1995033823A1 Methods for selectively stimulating proliferation of t cells
12/14/1995WO1995033493A1 Novel uses of triplex forming oligonucleotides for the treatment of human diseases
12/14/1995CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
12/14/1995CA2191586A1 Methods for selectively stimulating proliferation of t cells
12/13/1995EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
12/13/1995CN1113390A Defective adenovirus vectors and use thereof in gene therapy
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/07/1995WO1995033062A2 Method for introducing foreign matter into higher eukaryotic cells
12/07/1995WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells
12/07/1995WO1995033060A1 Method of cancer treatment by p53 protein control
12/07/1995WO1995033054A1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
12/07/1995WO1995032988A1 Novel parasite protease genes and proteins
12/07/1995WO1995032987A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/07/1995WO1995032986A1 Branched oligonucleotides as pathogen-inhibitory agents
12/07/1995WO1995032985A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer
12/07/1995WO1995032740A1 Transformed human hepatoma cell line which releases insulin
12/07/1995WO1995032731A2 Immunogenic pharmaceuticals
12/07/1995WO1995032706A1 Virosome-mediated intracellular delivery of therapeutic agents
12/07/1995WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/07/1995WO1995028907A3 Megapoietin: a novel megakaryocyte growth promoting factor
12/07/1995WO1995024485A3 Coordinate in vivo gene expression
12/07/1995DE4435919C1 DNA encoding zinc finger protein
12/07/1995DE4418965A1 Transfection of eukaryotic cells with nucleic acid
12/07/1995CA2191762A1 Method for introducing nucleic acid in higher eukaryotic cells
12/07/1995CA2190998A1 Branched oligonucleotides as pathogen-inhibitory agents
12/07/1995CA2190982A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer
12/07/1995CA2190963A1 Method for introducing foreign matter into higher eukaryotic cells
12/07/1995CA2189741A1 Novel parasite protease genes and proteins
12/06/1995EP0684955A1 Nuclear matrix proteins
12/06/1995EP0684842A1 Composition for use in the treatment of tumours and the immunization of humans and animals
12/06/1995EP0684764A1 Treatment of androgen-associated baldness using antisense oligomers
12/06/1995EP0673259A4 A method for transplanting cells into the brain and therapeutic uses therefor.
11/1995
11/30/1995WO1995032308A1 Compositions and uses thereof in the diagnosis of psoriasis
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032297A1 Novel chromosome fragment and its use as a vector
11/30/1995WO1995032285A2 Transgenic arthritic mice
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995WO1995030002A3 Enhancing the sensitivity of tumor cells to therapies
11/30/1995CA2190247A1 Safe vectors for gene therapy
11/30/1995CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis
11/29/1995EP0683668A1 Compositions and methods for transdermal drug delivery
11/28/1995US5470967 Oligonucleotide analogs with sulfamate linkages
11/28/1995US5470966 Neural α-catenin
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5469854 Methods of preparing gas-filled liposomes
11/23/1995WO1995031729A1 Nucleic acid sequences controlling lung cell-specific gene expression
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
1 ... 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 ... 870